Thanks to the considerable media attention attracted by Naltrexone (marketed by Orphan Australia Pty Ltd as ReVia), many Fellows will already be aware that since 1 March it has been available in Australia for the treatment of alcohol dependence. This is the first drug to be registered in Australia for the treatment of alcohol dependence in 50 years.
Get full access to this article
View all access options for this article.
References
1.
O'MalleySSJaffeAJChangGSchottenfeldRSMeyerRERounsavilleB. Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry1992; 49: 881–887.
2.
O'MalleySSCroopRSWroblewskiJMLabriolaDFVolpicelliJR. Naltrexone in the Treatment of Alcohol Dependence: A Combined Ananysis of Two Trials. Psychiatrus Annals11 November, 1995; 25.
3.
Austin and Repatriation Medical Centre and St Vincent's study into the treatment of alcohol dependency with Naltrexone, Preliminary report by Prof Philip Morris, Dr Mal Hopwood and Prof Greg Whelan.
4.
CroopRSFaulknerEBLabriolaDF. The safety profile of Naltrexone in the treatment of alcoholism: Results from a multicentre usage study. Archives of General Psychiatry1997; 54: 1130–1135.
